AstraZeneca plc

Advertisement

Trending AstraZeneca News

Eric Clapton claims vaccinated are victims of 'hypnosis'

Journal investigating study claiming Covid jab killed up to 280k in US

AstraZeneca admits its Covid vaccine CAN cause rare blood clotting

AstraZeneca plc - Latest news, breaking stories and comment

Page

DIRECTOR DEALS: Astrazeneca bosses splash out on more than £1m worth of shares

03/05/19 20:51

Chief executive Pascal Soriot, 59, bought 17,100 shares at a price of £58.26, spending £996,160. Philip Broadley, Astrazeneca’s 58-year-old non-executive director who is also on the board of Legal & General, bought 520 shares for £29,838....read

Astrazeneca sales continue to climb as UK drug firm is boosted by a new wave of cancer treatments
26/04/19 20:50
The British pharmaceuticals firm reported its third straight quarter of revenue growth for the three months to March 31, with sales rising 6 per cent to £4.3bn.
- 6 comments
- shares
MARKET REPORT: FTSE climbs on not-Brexit day but Astrazeneca slips after it asks for £2.7bn for its drug tie-up
29/03/19 21:51
Just over £1 billion from the cash call will go into the commercial tie-up with Daiichi Sankyo, which has developed a potential breakthrough treatment for HER2-positive strains of breast cancer.
- 1 comment
- 1 share
IN THE MONEY: Astrazeneca boss Pascal Soriot trousers £11.4m in annual pay
05/03/19 22:17
It means the Frenchman, credited with turning around the drug giant’s fortunes, has been handed an astonishing £54.6m since 2012. His pay for last year included £9.5m in bonuses.
- 1 comment
- shares
MARKET REPORT: Staying solo was the perfect remedy for AstraZeneca as it becomes the largest drug maker in the UK
27/02/19 21:51
This may sound a little unfair, but fund manager Neil Woodford has finally got something right, even if it has taken almost five years. He has come under fire of late for a string of horrible investment calls.
- comments
- 1 share
Astrazeneca hails success of new drugs and strong performance in China as it returns to sales growth for first time in decade
14/02/19 21:54
Sales rose 5 per cent to £4.5 billion in the final three months of 2018, bringing the total figure for the year to £16.4 billion.
- 1 comment
- shares
FTSE CLOSE: Airbus axes A380 superjumbo; Restaurant Group CEO goes after Wagamama deal; Drugs giant AstraZeneca bullish despite profits drop
14/02/19 08:11
In company news today, Airbus has taken the 'painful decision' to cease production of its superjumbo A380 aircraft amid dwindling demand and Restaurant Group's boss is stepping down.
- 20 comments
- shares
THE DAILY BRIEFING: Baroness Shriti Vadera is stepping down from the board of drugs giant Astrazeneca after eight years
14/12/18 23:06
Baroness Shriti Vadera is stepping down from the board of drugs giant Astrazeneca after eight years to be replaced by Tony Mok, a professor at the Chinese University of Hong Kong.
- 3 comments
- shares
Astrazeneca shares slide after one of its cancer treatments turns up disappointing results in study
16/11/18 21:50
The final part of the Mystic trial found immunotherapy drug Imfinzi failed to improve survival rates in patients with stage-four lung cancer, the most advanced kind.
- comments
- shares
Turning point for drugs giant as sales recover: Astrazeneca reports booming demand after eight years of decline
08/11/18 21:51
The Anglo-Swedish pharmaceuticals giant's boss Pascal Soriot hailed a turning point as his firm reported rising sales of its drugs. Sales rose 8 per cent to £4bn in the third quarter of the year.
- 1 comment
- shares
TRADER TIPS: City insiders say buy pharmaceutical giant Astrazeneca after positive drug trial results, but sell Serco as its market is 'tough'
01/07/18 21:02
Analysts said that Astra's results were in line with expectations, but they also expect positive news from a trial on prostate cancer patients. Serco has just acquired a number of hospitals from Carillion.
- comments
- shares
Blow for key lung cancer drug trial as pharmaceuticals giant Astrazeneca delays news of results
12/03/18 21:48
Astrazeneca has pushed back the release of results for a key lung cancer drug trial.
- comments
- 1 share
DAILY BRIEFING: AstraZeneca wins US approval for drug to treat severe asthma
15/11/17 22:00
Drugmaker AstraZeneca has won US approval for a treatment for severe asthma. Benralizumab will be marketed under the name Fasenra.
- comments
- 1 share
Iraq militia 'funded' by British drug giant Astrazeneca: Lawyers claim bribes paid for weapons that killed soldiers
29/10/17 21:57
Astra is one of several firms being dragged into a US court over allegations it bribed health officials who were aligned with Jaysh al-Mahdi, one of the most violent insurgent groups in Iraq.
- 8 comments
- 2 shares
Astrazeneca confirms expansion plan for biggest British site in major vote of confidence over Brexit
27/08/17 20:59
Andy Evans, head of Astra’s Macclesfield operations, told the Sunday Telegraph that the FTSE 100 firm will increase capacity at the site.
- 26 comments
- 10 shares
DAILY BRIEFING: AstraZeneca investor Woodford says share fall on Mystic results not justified
28/07/17 21:56
Top AstraZeneca shareholder Neil Woodford said a 16 per cent fall in the company’s share price after the failure of a high-profile cancer drug trial was unwarranted. ‘The investment case...
- comments
- shares
The £10BILLION drug trial calamity: AstraZeneca shares hammered as they fall 15% on dashed treatment hopes
27/07/17 21:03
Drug pioneer AstraZeneca suffered its biggest-ever daily share fall as its hopes of a breakthrough with a revolutionary lung cancer treatment suffered a blow.
- 2 comments
- 10 shares
Pharmaceutical giant AstraZeneca sees shares plummet 15% as lung cancer drug trial fails
27/07/17 10:28
The Anglo-Swedish company's stock sank to a record low of 4,300p in morning trading, making it the biggest loser on the FTSE 100.
- 5 comments
- shares
Astrazeneca's boss plays down rumours he is planning to leave - telling staff he plans to work ‘together’ to see company succeed
21/07/17 20:50
In an internal memo dated July 16, the drug giant’s chief executive Pascal Soriot did not confirm or deny reports he had accepted a job with Israel’s Teva Pharmaceutical Industries.
- 2 comments
- shares
AstraZeneca boss in denial on rumours he is leaving pharmaceuticals giant for Israeli rival
14/07/17 20:51
Pascal Soriot, 58, yesterday admitted speculation he was poised to become chief executive of Israeli firm Teva Pharmaceuticals was 'unfortunate indeed'.
- 1 comment
- shares
MARKET REPORT: AstraZeneca sinks as rumours fly that boss Pascal Soriot is set to quit for an Israeli rival
13/07/17 20:51
Investors fled after an Israeli newspaper reported that Soriot has met with Teva, the world’s largest generic drugmaker, where he could earn twice as much as the firm’s former boss.
- 3 comments
- shares
ALEX BRUMMER: Is AstraZeneca boss on his way to a huge payday at Israeli generics giant?
13/07/17 20:50
The lack of a convincing denial from AstraZeneca that its chief executive Pascal Soriot may be on his way to Israeli generics giant Teva will be hugely worrying for investors.
- 1 comment
- 1 share
MARKETS CLOSE: Footsie finishes flat, but AstraZeneca falls on reports boss Pascal Soriot could be off
13/07/17 07:14
The FTSE 100 closed down 3.49 points at 7,413.44 after barely budging this session.
- 3 comments
- 5 shares
AstraZeneca gets share lift on ground-breaking lung-cancer drug trials
12/05/17 20:51
The FTSE pharmaceutical firm soared 9 per cent or 428.5p to 5176p when it announced success in testing of its immunotherapy drug Imfinzi.
- comments
- 1 share
AstraZeneca sales slip as it struggles with drug patent expiry but pharma giant is propped up by emerging markets
27/04/17 11:02
FTSE 100 drug maker Astrazeneca has reported a 13 per cent slide in sales as it continues to face the headwind of some of its most successful drugs coming out of patent protection.
- comments
- 1 share
IN THE MONEY: Pascal Soriot, 57, Chief exec, AstraZeneca took home £13.4m last year
07/03/17 22:57
The boss of drugs giant AstraZeneca earned £13.4m last year after receiving compensation to make up for the amount he would have received in his previous job.
- comments
- 1 share
Flood of cheap generic alternatives for branded cholesterol medicine causes sales to slump for drug giant AstraZeneca
02/02/17 21:57
The pharmaceutical giant saw 2016 sales fall 5 per cent after struggling to overcome the decline of Crestor, its best-selling cholesterol treatment.
- 1 comment
- 2 shares
Pharmaceuticals giant AstraZeneca sees profits fall by more than a quarter as rivals challenge its leading cholesterol drug
10/11/16 21:49
Its patent on Crestor, a statin, expired this year, meaning competitors can now produce cheaper generic versions. This pushed US sales down by 82 per cent in the three months to September 30.
- comments
- 2 shares
AstraZeneca fined £4m for backhanders to doctors ... It set up bogus conferences, supplied fake travel invoices and handed gifts to hospitals
31/08/16 20:52
The US markets watchdog claims staff at the pharmaceuticals firm made ‘improper payments’ to doctors in China and Russia as incentives to buy or prescribe AstraZeneca medicines.
- 24 comments
- 10 shares
AstraZeneca strikes £1.2bn deal to sell part of antibiotics business to Pfizer - the US giant it fought off in 2014
24/08/16 10:23
AstraZeneca will get £550million (£379million) up-front, plus another $175million (£130million) in January 2019. The remaining amount will be paid out as manufacturing and sales develop.
- comments
- 1 share
DIRECTOR'S DEALS: Marc Dunoyer, 64 CFO at AstraZeneca snaps up 43,730 shares for £2.2m
03/08/16 20:51
The shares in the £62bn pharma giant cost £50.48 each, slightly ahead of yesterday’s price of 5016p. The shares were awarded as part of a performance share plan.
- comments
- 3 shares
Drugs giant invests £330m and says UK is still top for science: AstraZeneca gives vote of confidence just a day after rival firm also unveils plans to invest
28/07/16 23:28
Drugs giant AstraZeneca said yesterday that it is ‘hard to find a better place in the world’ to do science than Cambridge. It committed to spending £330million on research and development.
- 84 comments
- 865 shares
Pharmaceuticals giant AstraZeneca could become bid target again, firm's chief executive hints
28/07/16 22:01
Pascal Soriot, chief executive of the Anglo-Swedish pharmaceuticals giant, said potential suitors may emerge due to the growing value of its drugs pipeline.
- 3 comments
- 4 shares
Reckitt Benckiser and AstraZeneca become the latest British blue chips to face investor revolt
29/04/16 20:57
More than one in ten investors voted against the £8.4m Pascal Soriot was handed last year as chief executive of drug maker AstraZeneca.
- 5 comments
- 3 shares
UK drugmakers Shire, AstraZeneca and GlaxoSmithKline could be next on Pfizer's hit-list after deal with Allergan collapses
06/04/16 16:09
According to analysts, Pfizer needs to find a partner in its quest to relocate its headquarters and lower its 24 per cent tax rate - with the UK's top three drug firms all fitting the bill.
- 2 comments
- shares
MARKET REPORT: AstraZeneca on the hunt to boost its drugs pipeline amid rumours about potential bids for US group Medivation
31/03/16 20:56
Prostate cancer treatment firm Medivation has taken on JP Morgan to handle a number of approaches from rivals since the start of the year, according to sources cited in reports.
- 1 comment
- 1 share
Astrazeneca chief Pascal Soriot faces £3.5m pay revolt following profit warning
14/03/16 21:56
Soriot, who received total renumeration of £3.5m in 2014, had made a key pledge that revenues would reach £31.8bn by 2023 as a way of fending off an unwelcome approach from Pfizer.
- 1 comment
- shares
AstraZeneca wins 'breakthrough' status for bladder cancer treatment drug, Durvalumab, speeding up development
17/02/16 22:51
The drug’s new status, granted by US regulator, the Food and Drug Administration, will speed up its development but it has yet to be approved in Europe.
- comments
- 1 share
MARKET REPORT: AstraZeneca alert over cheap generic rivals to its anti-cholesterol drug sends shares plummeting 6%
04/02/16 21:56
Chief executive Pascal Soriot’s name was mud as many shareholders remember the revenue forecasts he plucked out of the sky after the board rejected Pfizer’s takeover bid in 2014.
- 2 comments
- 2 shares
AstraZeneca warns of profits and sales drop for 2016 as patent for blockbuster anti-cholesterol drug expires
04/02/16 11:59
The drugmaker, which two years ago saw off a takeover attempt by US giant Pfizer, now expects 'a low to mid single-digit percentage decline' in both sales and profits in 2016.
- 2 comments
- 7 shares

Page

FollowDailyMail
SubscribeDaily Mail
Follow@dailymail
FollowDailyMail
FollowMailOnline
FollowDaily Mail

DON'T MISS

Advertisement

Advertisement